Mr Brian Birch
- Remote consultations available
Last updated: 04/03/2025
Overview
35
|
total admissions. |
This information has been verified as accurate by the consultant
Last updated: 04/03/2025
35
|
total admissions. |
This information has been verified as accurate by the consultant
This information is provided by Mr Brian Birch.
GMC reg: 2524191Brian Robert Peter Birch Academic Qualifications · 1976 BA Natural Sciences, University of Cambridge, First Class Honours · 1976 Scholar St Catharine’s College, University of Cambridge · 1980 MB BChir University of Cambridge · 1985 Fellow of the Royal College of Surgeons of England (England) · 1995 MD (Cantab) National Research Ethics Service (NRES) · Expert member Local Research Ethics Committee (Hampshire B NRES committee) 2008 - 2015 · Vice Chair Local Research Ethics Committee (Southampton B NRES committee) 2021 onwards Service Development Local · Contributor to Map of Medicine for urology topics (e.g. haematuria, stones, UTI, prostate infection, acute urinary retention, erectile dysfunction etc.) · Member Chronic and Recurrent Abdominal Pain Steering Group (2016 to date) National · Contributor to NHS Choices Patient Information, NHS Research Priorities and the NHS Clinical Knowledge · Contributor to NIHR Health Technology Assessment (HTA) program Evaluation, Trials and Study co-ordinating centre: · 110761 NIHR Health Technology Assessment 11/142 Photodynamic guided treatment for bladder cancer 12 Dec 2012 · 110761 NIHR Health Technology Assessment 11/142 Photodynamic guided treatment for bladder cancer 23 Jan 2013 · 124842 NIHR Health Technology Assessment 16/167 HIVEC III: A randomised controlled trial comparing adjuvant recirculated hyperthermic intravesical chemotherapy (HIVEC™) with mitomycin C (MMC) vs Bacillus Calmette Guérin (BCG) in high risk non muscle invasive bladder cancer (HRNMIBC) 04 Aug 2017 · 11/142/02 PHOTOdynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a randomised trial of clinical and cost-effectiveness (the PHOTO RCT) 19 March 2021 · 14/08/60 BladderPath: Image Directed Redesign of Bladder Cancer Treatment Pathways 25 April 2021 · 160459 NIHR Health Technology Assessment Combination chemotherapy versus Bacillus Calmette-Guérin (BCG) for high-risk non-muscle invasive bladder cancer– a phase III multi-centre randomised controlled trial (COBRA) 14 Jan 2024
Urology - Urology Oncology • Urology - Erectile Dysfunction • Urology - Vasectomy • Urology - General Urology • Urology - Benign Prostatic Disease
These include: 1. Benign prostate disease: Urinary symptoms, prostate surgery, chronic prostatitis 2. Female urological dysfunction: Recurrent UTI, interstitial cystitis 3. Prostate cancer 4. Bladder cancer 5. Chronic pain in urology: interstitial cystitis, chronic prostatitis, Painful bladder syndrome, chronic pelvic pain syndrome, testicular pain 6: Andrology: vasectomy, testosterone replacement therapy
Surveys from patients about the care they received from Mr Brian Birch.
…
|
Not enough data available to show patient satisfaction feedback. |
…
|
Not enough data available to show patient experience feedback. |
Prices provided by Mr Brian Birch and their associated hospitals.
Nuffield Health Wessex Hospital
Spire Southampton Hospital
Nuffield Health Wessex Hospital
Use our interactive chart to explore more fees information in your area .